Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance

作者：Mei-Qing Cheng, Hang-Tong Hu, Shaohong Wu, Hui Huang, Ya-Dan Lin, Wenjuan Tong, Xiao-Zhou Lu, Wei-Ping Ke, Rui-Fang Lu, Qian-Qian Xu, Yu Wang, Xin-Xin Lin, Ze-Zhi Liu, Zhi-Rong Lu, Ming-De Lu, Hong Yang, Wei Wang, Li‐Da Chen · 发表于：Radiology · 年份：2026 · DOI：10.1148/radiol.252252 · 被引用次数：2 · 研究领域：Hepatocellular Carcinoma Treatment and Prognosis、Liver Disease Diagnosis and Treatment、Genetic and Kidney Cyst Diseases

American Association for the Study of Liver Diseases (AASLD) version 2023, which incorporates visualization score VIS-C, increasing α-fetoprotein level, and lesion growth, improved sensitivity and negative predictive value for hepatocellular carcinoma surveillance, outperforming US Liver Imaging Reporting System version 2017 and AASLD version 2018.